Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLOROX CO /DE/ Director's Dealing 2012

Aug 8, 2012

30403_dirs_2012-08-08_292d4864-5d08-4874-a52d-78f83c38056f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2012-08-06

Reporting Person: MATSCHULLAT ROBERT W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-06 Common Stock M 3000.0000 $53.7800 Acquired 4324.0000 Direct
2012-08-06 Common Stock M 3000.0000 $42.6500 Acquired 7324.0000 Direct
2012-08-06 Common Stock S 3000.0000 $71.7023 Disposed 4324.0000 Direct
2012-08-06 Common Stock S 3000.0000 $71.6589 Disposed 1324.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-13 Deferred Stock Units $ A 548.6600 Acquired Common Stock (548.6600) Direct
2012-05-11 Deferred Stock Units $ A 549.5400 Acquired Common Stock (549.5400) Direct
2012-08-06 Stock Option (Right to Buy) $42.6500 M 3000.0000 Disposed 2013-07-01 Common Stock (3000.0000) Direct
2012-08-06 Stock Option (Right to Buy) $53.7800 M 3000.0000 Disposed 2014-07-01 Common Stock (3000.0000) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $71.70 to $71.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This transaction was executed in multiple trades at prices ranging from $71.65 to $71.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: 1-for-1

F4: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F5: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.